Olesen Jens Steen, Wang Mikala, Wejse Christian
Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark.
Department of Microbiology, Aarhus University Hospital, Aarhus N, Denmark.
BMJ Case Rep. 2017 Jan 30;2017:bcr2016217257. doi: 10.1136/bcr-2016-217257.
A 66-year-old multimorbid man with rheumatoid arthritis developed an infection after a steroid injection in the hand. Mycobacterium chelonae was cultured 1-month after presentation. In the mean time, his third finger had been amputated. Further treatment was based on preliminary susceptibility testing and the American Thoracic Society guidelines. No regression of the infection was observed before the addition of linezolid (600 mg×1/day) to a combination antimicrobial therapy also consisting of clarithromycin (500 mg×2/day) and moxifloxacin (400 mg×1/day), even though two methods of susceptibility testing, the E-test and broth microdilution, had shown susceptibility to other antimicrobial drugs. The healing was complete 12 months after presentation. There were no serious side effects observed with the use of linezolid in reduced dosage of 600 mg×1/day for a duration of 9 months.
一名患有类风湿性关节炎的66岁多病男性在手部接受类固醇注射后发生感染。就诊1个月后培养出龟分枝杆菌。与此同时,他的无名指已被截肢。进一步的治疗基于初步药敏试验和美国胸科学会指南。在抗菌联合治疗方案(包括克拉霉素500mg×2/日和莫西沙星400mg×1/日)中加用利奈唑胺(600mg×1/日)之前,尽管两种药敏试验方法(E-test和肉汤微量稀释法)显示对其他抗菌药物敏感,但感染并未消退。就诊12个月后愈合完全。使用剂量减至600mg×1/日、持续9个月的利奈唑胺未观察到严重副作用。